Literature DB >> 21951304

Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008.

Hidetoshi Takahashi1, Koichiro Nakamura, Fumio Kaneko, Hidemi Nakagawa, Hajime Iizuka.   

Abstract

A survey of psoriasis patients from 1982-2001 has been reported by the Japanese Society for Psoriasis Research. The aim of this study is to analyze psoriasis patients in Japan registered from 2002-2008. A total of 11 631 cases were registered from 152 dermatological institutions in Japan. Males (7738 cases, 66.5%) were predominant over females (3893 cases, 33.5%). The clinical types of psoriasis were psoriasis vulgaris (88.5%), guttate psoriasis (3.9%), psoriasis arthropathica (3.3%), generalized pustular psoriasis (1.3%), psoriatic erythroderma (1.2%), localized pustular psoriasis (0.9%) and infantile psoriasis (0.1%). Topical corticosteroids (85.4%) and vitamin D(3) (59.7%) products were the main previous topical agents. Previous systemic treatments included etretinate (8.8%), cyclosporin (8.3%) and methotrexate (2.0%). Use of topical vitamin D(3) and systemic cyclosporin therapies has been increasing during the past 7 years. Topical psoralen and ultraviolet A therapy (PUVA) (7.6%) was the predominant phototherapy followed by UV-B (7.3%) and systemic PUVA (4.7%). Use of UV-B phototherapy has been increasing during the past 5 years. The survey of Japanese psoriasis patients during 2002-2008 disclosed that psoriasis arthropathica is more prevalent (1%) than that of the previous survey during 1982-2001. Use of topical vitamin D(3) and systemic cyclosporin has been increasing during the past 7 years.
© 2011 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951304     DOI: 10.1111/j.1346-8138.2010.01145.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  13 in total

1.  Clinical features of psoriatic uveitis in Japanese patients.

Authors:  Rie Tanaka; Mitsuko Takamoto; Keiko Komae; Kazuyoshi Ohtomo; Yujiro Fujino; Toshikatsu Kaburaki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-01       Impact factor: 3.117

2.  Identification of Two Loci Associated with Generalized Pustular Psoriasis.

Authors:  Zheng Zhang; Ying Ma; Zhenghua Zhang; Jinran Lin; Guoliang Chen; Ling Han; X U Fang; Qiong Huang; Jinhua Xu
Journal:  J Invest Dermatol       Date:  2015-03-24       Impact factor: 8.551

3.  Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".

Authors:  Yasuyuki Kamata; Seiji Minota
Journal:  Rheumatol Int       Date:  2017-12-05       Impact factor: 2.631

4.  Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.

Authors:  Kiyoshi Kubota; Yukari Kamijima; Tsugumichi Sato; Nobuhiro Ooba; Daisuke Koide; Hajime Iizuka; Hidemi Nakagawa
Journal:  BMJ Open       Date:  2015-01-14       Impact factor: 2.692

5.  Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.

Authors:  Akihiko Asahina; Takafumi Etoh; Atsuyuki Igarashi; Shinichi Imafuku; Hidehisa Saeki; Yoshiyuki Shibasaki; Yukiko Tomochika; Shigeyuki Toyoizumi; Makoto Nagaoka; Mamitaro Ohtsuki
Journal:  J Dermatol       Date:  2016-02-15       Impact factor: 4.005

6.  Anti-p200 Pemphigoid: A Systematic Review.

Authors:  Khalaf Kridin; A Razzaque Ahmed
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

7.  Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database.

Authors:  Jin Yong Lee; Sungchan Kang; Jong Seo Park; Seong Jin Jo
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

8.  The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE).

Authors:  Hae Jun Song; Chul Jong Park; Tae Yoon Kim; Yong Beom Choe; Seok-Jong Lee; Nack In Kim; Jae We Cho; Jie Hyun Jeon; Min Soo Jang; Jai Il Youn; Myung Hwa Kim; Joonsoo Park; Ki Ho Kim; Byung Soo Kim; Sang Woong Youn; Joo-Heung Lee; Min-Geol Lee; Sung Ku Ahn; Young Ho Won; Seok Kweon Yun; Bong Seok Shin; Seong Jun Seo; Ji Yeoun Lee; Kwang Joong Kim; Young Suck Ro; Youngdoe Kim; Dae Young Yu; Jee-Ho Choi
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

Review 9.  Risk Factors for the Development of Psoriasis.

Authors:  Koji Kamiya; Megumi Kishimoto; Junichi Sugai; Mayumi Komine; Mamitaro Ohtsuki
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

10.  Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis.

Authors:  Hidemi Nakagawa; Yoshiya Tanaka; Shigetoshi Sano; Hideto Kameda; Atsuo Taniguchi; Tomoko Kashiwagi; Takeshi Kawaberi; Junko Kimura; Akimichi Morita
Journal:  Adv Ther       Date:  2019-01-19       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.